View Older Stories View More Recent Stories
-
Cara Therapeutics Announces Proposed Offering of Common Stock
-
UPDATE: Janney Montgomery Scott Downgrades Waters Corp. (WAT) to Neutral
-
Saratoga Investment Corp. Announces Completion of Public Offering of 1,150,000 Shares of Common Stock
-
Janney Montgomery Scott Starts Quaker Chemical Corporation (KWR) at Neutral
-
Janney Montgomery Scott Downgrades STORE Capital (STOR) to Neutral
-
Janney Welcomes 45 New Hires to the Firm’s Private Client Group in Second Quarter of 2018
-
Weather Causes Cedar Fair L.P. (FUN) Revs To Drop Y/Y, PT To $73 - Janney
-
Saratoga Investment (SAR) Prices 1.15M Share Common Offering at $25/Sh
-
Saratoga Investment Corp. Announces Pricing of Public Offering of Common Stock
-
Saratoga Investment (SAR) Announces Proposed 1M Share Common Share Offering
-
Saratoga Investment Corp. Announces Commencement of Public Offering of Common Stock
-
Janney Montgomery Scott Upgrades USD Partners LP (USDP) to Buy
-
Thoughts From Playa Hotels & Resorts (PLYA) Analyst Day - Janney
-
UPDATE: Janney Montgomery Scott Upgrades DepoMed Inc (DEPO) to Buy
-
Janney Montgomery Scott Starts Champions Oncology (CSBR) at Buy
-
Investors to tune in for trade impact this profit season
-
Dollar drops to three-week low as euro rises; U.S. payrolls in focus
-
Wall Street set to open higher as oil prices rise
-
Wall Street ekes out gain as Nike surges
-
Janney Upgrades Ally Financial (ALLY) to Buy
-
Janney Montgomery Scott Upgrades Santander Consumer USA Holdings Inc. (SC) to Buy
-
Form MA-I/A JANNEY MONTGOMERY SCOTT
-
Form MA-I/A JANNEY MONTGOMERY SCOTT
-
uniQure BV (QURE) Fair Value Target Raised to $50 at Janney Montgomery Scott
-
Janney Starts Strongbridge Biopharma (SBBP) at Buy, Says Co. Strategically Building a Therapeutically Aligned Rare Disease Platform
-
Janney Downgrades Summit Therapeutics plc (SMMT) to Neutral
-
Janney Downgrades Summit Therapeutics plc (SMMT) to Neutral
-
Janney Montgomery Scott Starts Clearside Biomedical (CLSD) at Buy
-
Janney Montgomery Scott Starts ContraFect Corp. (CFRX) at Buy
-
CM Finance Inc Prices Public Offering of $30,000,000 6.125% Notes Due 2023
-
CM Finance Inc Prices Public Offering of $30,000,000 6.125% Notes Due 2023
-
Pre-Open Movers 06/27: (DFBG) (CARA) (I) Higher; (AQXP) (PTIE) (DRRX) Lower (more...)
-
CM Finance Inc Commences Offering of Notes
-
CM Finance Inc Commences Offering of Notes
-
Clark Capital Management Group Welcomes Eric Kazatsky to Fixed Income Team
-
Clark Capital Management Group Welcomes Eric Kazatsky to Fixed Income Team
-
Clark Capital Management Group Welcomes Eric Kazatsky to Fixed Income Team
-
Clark Capital Management Group Welcomes Eric Kazatsky to Fixed Income Team
-
UPDATE: Janney Starts Selecta Biosciences (SELB) at Buy
-
Janney Montgomery Scott Starts Fluidigm Corporation (FLDM) at Neutral
-
Janney Starts Avid Bioservices (CDMO) at Buy
-
Janney Montgomery Scott Upgrades Eversource Energy (ES) to Buy
-
Enova International (ENVA) PT Raised to $38 at Janney Montgomery Scott
-
Janney Montgomery Scott Reiterates Buy on Flexion Therapeutics (FLXN) Following ANIK Announcement
-
Sarepta Therapeutics (SRPT) PT Raised to $200 at Janney Montgomery Scott
-
Experienced Public Finance Bankers Joe Bosch, Dan Froehlich Join D.A. Davidson to Focus on Higher Ed, Nonprofit Finance
-
Janney Downgrades Rent-A-Center (RCII) to Neutral Following Acquisition Offer
-
Computerworld Names the 2018 Best Places to Work in IT
-
SeaWorld Entertainment (SEAS) PT Raised to $25 at Janney Following Management Meeting
-
Janney Montgomery Scott Downgrades AMAG Pharmaceuticals (AMAG) to Neutral

